#news #biotech J&J’s nasal antidepressant heads for FDA panel

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: J&J’s nasal antidepressant heads for FDA panel .Johnson & Johnson’s new antidepressant esketamine comes in front of an FDA advisory committee tomorrow, hoping to end a drought in novel therapies for the disorder.

from FierceBiotech: Biotech http://bit.ly/2RUxxun